The FDA has accepted for Priority Review the sNDA for finerenone for heart failure with mildly reduced or preserved ejection fraction.

High cholesterol causes plaque buildup in arteries, which can restrict blood flow and lead to heart attack or stroke. Statins, which reduce cholesterol levels, are commonly prescribed to people at ...

Our findings suggest deeper issues are contributing to the increase in the disease, particularly in Black women. Barriers to health care are critical. These include insurance gaps, transportation ...

Signals from the epicardium are essential for fetal coronary lymphangiogenesis. VEGFC and VEGFD produced by the epicardium ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...